Chronic lung infections caused by Pseudomonas aeruginosa play a significant role in the
mortality and morbidity of cystic fibrosis (CF) patients. The widespread bacterial resistance to …

Therapy of lung infections sustained by Pseudomonas aeruginosa in cystic fibrosis (CF)
patients is challenging due to the presence of a sticky mucus in the airways and the ability of …

Aim: This study aims to verify the antibacterial and antibiofilm action of cell-free spent
medium (CFSM) from four lactic acid bacteria with potential probiotic characteristics …

Background Pseudomonas aeruginosa is an opportunistic pathogen that significantly
increases morbidity and mortality in nosocomial infections and cystic fibrosis patients. Its …

No prevalence or dynamics analysis of Lactobacilli in the lung of cystic fibrosis (CF) patients
has yet been conducted. In order to use them as probiotics in the treatment of Pseudomonas …

Objectives The aim of the project was to develop and characterise powders containing a
probiotic (Lactiplantibacillus plantarum [Lpb. plantarum], Lacticaseibacillus rhamnosus, or …

Background: Pseudomonas aeruginosa, as an important opportunistic pathogen, can
produce P. aeruginosa. biofilm. Intrinsically resistant to antimicrobial agent, the biofilm …

The spreading of antibiotic resistance is a major public health issue, which requires
alternative treatments to antibiotics. Lactobacilli have shown abilities to prevent pneumonia …

Ciprofloxacin and streptomycin are frequently prescribed for the treatment of medical
conditions originating due to infection by Pseudomonas aeruginosa. However …

Pseudomonas aeruginosa can cause persistent infections, such as biofilm infections, in
cystic fibrosis patients, which are difficult to cure due to non-growing persister bacteria that …